No abstract available
Publication types
-
Letter
-
Multicenter Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Brentuximab Vedotin
-
Hodgkin Disease* / drug therapy
-
Humans
-
Immunoconjugates*
-
Lymphoma, Large-Cell, Anaplastic* / drug therapy
-
Neoplasm Recurrence, Local / drug therapy
-
Retreatment
-
Retrospective Studies
Substances
-
Immunoconjugates
-
Brentuximab Vedotin